Can parasites cause the reappearance of fetal hemoglobin (HbF)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Parasitic Infections and Fetal Hemoglobin (HbF)

Parasitic infections can cause anemia but there is no evidence that they directly induce reappearance of fetal hemoglobin (HbF) in adults. Rather, the relationship appears to be the opposite - HbF provides protection against certain parasitic infections, particularly malaria.

Parasitic Infections and Hematological Effects

Intestinal Parasites

  • Intestinal parasitic infections during pregnancy can cause significant hematological changes:
    • Decreased hemoglobin (HGB), hematocrit (HCT), mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), and mean corpuscular hemoglobin concentration (MCHC) 1
    • Hookworm, Schistosoma mansoni, and Ascaris lumbricoides infections are strongly associated with anemia in pregnant women 1
    • These parasites primarily cause anemia through blood loss, impaired nutrient absorption, and inflammation

Malaria and HbF

  • The relationship between parasites and HbF is best documented with malaria, but in the reverse direction:
    • HbF provides protection against malaria parasites, particularly Plasmodium falciparum 2, 3
    • Parasites show retarded growth in red blood cells containing HbF 3, 4
    • This protective effect appears to be due to HbF's resistance to digestion by malarial hemoglobinases 2
    • HbF forms a super stable tetramer that is digested only half as well as adult hemoglobin (HbA) by parasite enzymes 2

Mechanisms of Protection by HbF Against Malaria

  • Several mechanisms have been proposed for how HbF protects against malaria:

    • Inhibition of schizont division in HbF-containing red blood cells, resulting in fewer merozoites 5
    • Slower development of parasites in HbF-containing cells 2, 4
    • Defective hemozoin formation in HbF-containing cells 2
  • This protective effect explains:

    • The relative resistance to malaria in the first few months of life when HbF levels are high 3, 5
    • Potential selective advantage for individuals with thalassemia and sickle cell trait, who maintain higher HbF levels for longer periods 3, 4

Clinical Implications

  • When evaluating anemia in patients with parasitic infections:

    • Consider the direct effects of parasites on red blood cell parameters
    • Assess for intestinal blood loss with hookworm and schistosomiasis
    • Monitor for severe anemia, especially in pregnant women 6
    • Be aware that certain parasitic infections can lead to non-immune hydrops fetalis through anemia, anoxia, endothelial cell damage, and increased capillary permeability 6
  • For pregnant women with parasitic infections:

    • Screen for anemia and treat appropriately
    • Consider deworming before pregnancy to minimize maternal anemia 1
    • In cases of severe anemia with disseminated intravascular coagulation (DIC), address coagulopathy before blood transfusion 7

Important Caveats

  • While parasitic infections can cause anemia, there is no evidence they directly stimulate HbF production
  • The protective effect of HbF against malaria is well-documented, but this represents the opposite relationship from what the question asks
  • The presence of HbF in adults is typically due to other factors such as hereditary persistence of fetal hemoglobin, certain hemoglobinopathies, or bone marrow stress from other causes
  • When evaluating elevated HbF in adults with parasitic infections, consider other underlying conditions that might explain both findings

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.